By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PAREXEL International 

Corporate Headquarters
195 West Street
Waltham  Massachusetts  02451  U.S.A.
Phone: 781-487-9900 Fax: 781-487-0525


SEARCH JOBS

THE CLEAREST PATH TO CAREER FULFILLMENT STARTS WITH PAREXEL.

At PAREXEL, the best minds in the industry are simplifying the journey from science to new treatments—and getting them into the hands of those who need them most. If you join us, you can be a part of that. Through innovative processes and technology, your journey with us will not only be challenging but truly rewarding. PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.

Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.

PAREXEL Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates approximately 75 locations in over 50 countries around the world, and has more than 15,000 employees. For more information about PAREXEL International, visit www.PAREXEL.com.


Key Statistics


Email: info@PAREXEL.com
Ownership: Public

Web Site: PAREXEL
Employees: 15,000 worldwide
Symbol: PRXL
 









Company News
PAREXEL (PRXL) Announces $200 Million Accelerated Share Repurchase Program 11/22/2016 10:31:25 AM
PAREXEL (PRXL) Launches IDMP-Focused Software And Service Solution 11/14/2016 10:53:01 AM
PAREXEL (PRXL) Reports First Quarter Fiscal Year 2017 Results And Announces New Share Repurchase Program 10/27/2016 11:05:30 AM
PAREXEL (PRXL) Announces Date Of First Quarter Fiscal Year 2017 Earnings Release And Conference Call 10/13/2016 12:04:22 PM
PAREXEL (PRXL) Launches Active Tracking Service For Monitoring And Managing Temperature-Controlled Investigational Medicinal Products 10/6/2016 7:35:30 AM
PAREXEL (PRXL) Announces Execution Of Definitive Agreement To Acquire Execupharm 9/26/2016 11:00:13 AM
Christian Dreger Joins PAREXEL (PRXL) As Senior Vice President, PAREXEL Access And PAREXEL Consulting 9/19/2016 11:58:47 AM
PAREXEL (PRXL) To Present At Wells Fargo Healthcare Conference 9/1/2016 10:43:21 AM
PAREXEL (PRXL) Loses $160 Million in Value in One Day After Disclosing Possible 'Misappropriation of Corporate Funds' 9/1/2016 5:56:26 AM
PAREXEL International (PRXL)’s Head Of BioPharm Unit Named To The 2016 PharmaVOICE 100 8/15/2016 12:28:47 PM
12345678910...
//-->